Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cidra Corporation
New business venture formed to commercialize microparticle technology
January 14th, 2004
Cidra Corporation announced that it has formed a new venture named CyVera Corporation, whose mission is to commercialize life sciences applications of its digitally encoded microparticle (bead) technology. CyVera's initial products will provide a versatile platform for the expanding genomics and proteomics measurements markets. This digitally encoded genomics/proteomics platform has unprecedented microparticle code density, yielding practically unlimited multiplexing, higher sample throughput, increased flexibility/customizability and lower measurement cost. CyVera's platform will cover the R&D to diagnostic market sectors, and supports standard...
Source: Biotech Week (2004-01-14)
|
